New Delhi, November 19 (Udaipur Kiran). Sudeep Pharma Limited will open its initial public offering (IPO) on 21 November, with the issue remaining open for subscription till 25 November. The company has set the price band at ₹563–593 per equity share.
For its first IPO, the company has fixed the price band at ₹563–593 for each equity share with a face value of ₹1. Sudeep Pharma aims to raise ₹895 crore through this public issue. Investors can place bids for a minimum of 25 equity shares and in multiples of 25 thereafter.
The IPO comprises a fresh issue of ₹95 crore and an offer for sale (OFS) of up to 13,490,726 shares worth ₹800 crore by the promoter and promoter group shareholders. From the fresh issue proceeds, the company will allocate ₹75.8 crore for purchasing machinery for the production line at its Nandesari Facility 1 in Gujarat and for capital expenditure under general corporate purposes. The remaining amount will be used for other general corporate requirements. The company aims to expand its operations and strengthen its technology infrastructure through this investment.
Sudeep Pharma Limited is a technology-driven company engaged in manufacturing excipients and specialty ingredients used across the pharmaceutical, food and nutrition sectors. The company works entirely on in-house technology, involving advanced processes such as encapsulation, spray drying, granulation, blending and liposomal preparation. It has a presence in more than 100 countries and a strong footprint in major markets including the US, Europe, South America, the Middle East, Africa and the Asia-Pacific region.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.